Tag results:
CXCR3
Pancreatic Cell News
Pro-Inflammatory β Cell Small Extracellular Vesicles Induce β Cell Failure through Activation of the CXCL10/CXCR3 Axis in Diabetes
[Cell Reports] Scientists reported that pro-inflammatory β cell small extracellular vesicles induced β cell dysfunction, promoted a pro-inflammatory islet transcriptome, and enhanced recruitment of CD8+ T cells and macrophages.
Human Immunology News
Natural Killer Cell Immunosuppressive Function Requires CXCR3-Dependent Redistribution within Lymphoid Tissues
[Journal of Clinical Investigation] Scientists showed that natural killer (NK)-cell suppression of T cells is associated with transient accumulation of NK cells within T cell-rich sites of the spleen during lymphocytic choriomeningitis virus infection.
Immune Regulation News
12-Lipoxygenase Governs the Innate Immune Pathogenesis of Islet Inflammation and Autoimmune Diabetes
[JCI Insight] Investigators showed that macrophages contributed significantly to the loss of β-cells and the subsequent development of hyperglycemia. Depletion or inhibition of 12-LOX in this model resulted in reduced macrophage infiltration into islets and the preservation of β-cell mass.
Hepatic Cell News
PKM2-Dependent Metabolic Skewing of Hepatic Th17 Cells Regulates Pathogenesis of Non-alcoholic Fatty Liver Disease
[Cell Metabolism] Scientists uncovered and characterized a distinct population of inflammatory hepatic CXCR3+Th17 (ihTh17) cells sufficient to exacerbate non-alcoholic fatty liver disease pathogenesis.
Human Immunology News
PKM2-Dependent Metabolic Skewing of Hepatic Th17 Cells Regulates Pathogenesis of Non-Alcoholic Fatty Liver Disease
[Cell Metabolism] Scientists uncovered and characterized a distinct population of inflammatory hepatic CXCR3+Th17 cells sufficient to exacerbate non-alcoholic fatty liver disease pathogenesis.
Cancer Stem Cell News
Biased Action of the CXCR4-Targeting Drug Plerixafor Is Essential for Its Superior Hematopoietic Stem Cell Mobilization
[Communications Biology] Scientists showed that while AMD11070 acts as a full antagonist, plerixafor acts biased by stimulating β-arrestin recruitment while fully antagonizing G protein.